Risk Factors for Breast Cancer
The most important risk factors for breast cancer include genetic predisposition (BRCA1/2 and other mutations), exposure to estrogens (endogenous and exogenous including long-term hormone replacement therapy), ionizing radiation, low parity, high breast density, history of atypical hyperplasia, Western-style diet, obesity, and alcohol consumption. 1
Non-Modifiable Risk Factors
Genetic and Familial Factors
- BRCA1/2 mutations carry the highest genetic risk, with lifetime breast cancer risk of 50-85% for BRCA1 carriers and approximately 45% for BRCA2 carriers 2
- Other high-risk genetic mutations include TP53 (Li-Fraumeni syndrome), PTEN (Cowden syndrome), CDH1, STK11 (Peutz-Jeghers syndrome), PALB2, and ATM genes 2
- Women of Ashkenazi Jewish descent have increased incidence of BRCA1/2 mutations 2, 3
- Strong family history increases risk even without identified genetic mutations—the number of affected first-degree relatives and their age at diagnosis are critical considerations 2
- First-degree relatives with breast cancer confer at least a 2-fold increased risk in women aged 40-49 years 4
Age and Demographics
- Increasing age is the most important risk factor for most women 5
- Approximately 25% of breast cancers occur before age 50, and less than 5% before age 35 1
- Race matters: White and Black women have the highest incidence rates, though Black women have 39% higher death rates despite similar incidence 2
Breast Density
- Extremely dense breasts (BI-RADS category D) are associated with at least a 2-fold increase in breast cancer risk in women aged 40-49 years 4
- High breast density is a well-established independent risk factor 1
Prior Radiation Exposure
- Chest/mantle radiation before age 30 (e.g., for Hodgkin lymphoma) significantly increases risk 1, 2
- Cumulative risk for Hodgkin lymphoma survivors treated at age 25 reaches 20-25% by age 45 2
- Any woman receiving ≥10 Gy cumulative dose before age 30 is considered high risk 2
Personal History of Breast Disease
- Prior breast cancer: Risk of contralateral cancer is 0.5-1% per year during the first 10 years after diagnosis 2
- Lobular carcinoma in situ (LCIS): Lifetime risk of 10-20%, with 6- to 10-fold relative risk for invasive cancer 2
- Atypical ductal hyperplasia (ADH): 4- to 5-fold relative risk; cumulative 10-year risk is 2.6 times higher 2
- Prior breast biopsy (especially with atypia): 1.5- to 2.0-fold increased risk 4
Modifiable Risk Factors
Hormonal Exposures
- Long-term hormone replacement therapy (HRT): Pooled odds ratio of 1.23 (95% CI 1.21-1.25) 6
- Current oral contraceptive use: Pooled odds ratio of 1.10 (95% CI 1.03-1.18), representing 1.0- to 1.5-fold increased risk 4, 6
- Endogenous estrogen exposure: Early menarche, late menopause, nulliparity, and late age at first birth all increase risk 1, 3
Reproductive Factors
- Nulliparity or age ≥30 years at first birth: 1.0- to 1.5-fold increased risk 4
- Prolonged interval between menarche and first live birth increases risk 3
- Breastfeeding is protective: Pooled odds ratio of 0.72 (95% CI 0.58-0.89) for ever-breastfeeding 6
Lifestyle and Metabolic Factors
- Obesity: Independent risk factor, especially in postmenopausal women, attributed to increased circulating endogenous estrogen from adipose tissue 3
- High BMI and adult weight gain: Stronger association for hormone-positive tumors in postmenopausal women 3
- Alcohol consumption: Contributes to rising incidence 1
- Western-style diet: Associated with increased risk 1
- Diabetes mellitus: Pooled odds ratio of 1.14 (95% CI 1.09-1.19) 6
- Low physical activity: Identified as modifiable risk factor 7
Risk Stratification Framework
The most recent guidelines 8 categorize women into three risk groups based on estimated lifetime risk:
- Average risk: <15% lifetime risk
- Intermediate risk: 15-20% lifetime risk
- High risk: >20% lifetime risk, including:
- Carriers of deleterious genetic mutations
- Untested first-degree relatives of mutation carriers
- History of chest radiation before age 30
- Certain combinations of personal history factors
Clinical Pitfalls to Avoid
Don't overlook family history assessment: The ACR recommends breast cancer risk assessment by age 25 to identify elevated-risk patients who benefit from earlier, more aggressive screening 8, 9
Black women require special attention: Despite similar incidence to white women, they have significantly higher mortality and are twice as likely to die of early breast cancers, partly due to higher rates of triple-negative breast cancer 2
Dense breasts require action: Women with BI-RADS category C or D density need consideration for supplemental screening modalities 8
Multiple risk factors compound: Women with personal history of breast cancer diagnosed at age ≤50 and treated with breast-conserving therapy have ≥20% lifetime risk for new breast cancer 2